Development and validation of a perinatal risk prediction model for recurrent respiratory tract infections in moderate-to-late preterm infants: a retrospective cohort study

This study presents a novel risk stratification tool that effectively identifies high-risk moderate-to-late preterm infants and facilitates targeted interventions, such as RSV prophylaxis and enhanced immune monitoring. This advancement enables tailored RSV immunoprophylaxis planning in low-resource Asian NICUs. Nonetheless, further multi-center validation studies are warranted to confirm the model's generalizability and to refine its predictive accuracy for broader clinical application.